BMS-986470

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986470, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease [Phase 1, Phase 2]